Cerevel Therapeutics Holdings, Inc. (CERE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 6.87B |
| Enterprise Value | 6.36B |
| P/E Ratio | -16.83 |
| PEG Ratio | 2.47 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 10.81 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -18.46 |
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | March 31, 2024 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.35 |
| Return On Equity | -0.72 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -5.63M |
| EBITDA | -416.15M |
| Net Income | -432.84M |
| Diluted EPS | -2.67 |
| Total Cash | 846.29M |
| Total Cash/Share | 9.66 |
| Total Debt | 368.3M |
| Total Debt/Equity | 0.71 |
| Current Ratio | 10.92 |
| Book Value Per Share | 4.16 |
| 52-Week Change | 87.88 |
| 52-Week High | 44.99 |
| 52-Week Low | 19.59 |
| Moving Average 50 Days | 41.6 |
| Moving Average 200 Days | 38.67 |
| Average Volume | 2.06M |
| Shares Outstanding | 182.2M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |